4650EGP
- Active ingredient
- terlipressin
- Strength
- 1 mg/8.5ml
- Form
- ampoule
- Manufacturer
- ferring pharmaceuticals > multipharma
- Route
- injection
Uses
Used to improve kidney function in adults with hepatorenal syndrome associated with rapid decline in renal function.
Do not use if
Contraindicated in patients with hypoxia, worsening respiratory symptoms, or ongoing ischemic disease.
Side effects
Abdominal pain, nausea, diarrhea, shortness of breath, and respiratory complications may occur.
Warnings
Can cause serious or fatal respiratory failure and ischemic events. Close monitoring is required.
How it works
Synthetic vasopressin analog acting mainly on V1 receptors, producing vasoconstriction and improving renal perfusion in hepatorenal syndrome.
Storage
Store refrigerated at 2–8°C and protect from light.
